nav-left cat-right
cat-right

PharmaGap completes acute toxicity tests for lead ...

OTTAWA, May 17 /CNW Telbec/ – PharmaGap Inc. (TSX-V: GAP) (“PharmaGap” or “the Company”) today announced the formal completion of acute toxicity testing in mice for its lead cancer drug, PhG alpha 1. Testing took place in Ottawa at accredited facilities operated by the Institute of Biological Sciences, part of the National Research Council of Canada, under the supervision of an independent...

Odyssey Thera Initiates Project With Pfizer Inc.

SAN RAMON, Calif., May 17 /PRNewswire/ — Odyssey Thera, Inc. announced today an expanded agreement with Pfizer Inc. to profile compounds across Odyssey Thera’s panel of cell-based assays in order to characterize mechanism of action and pathway activity in human cells. Odyssey Thera’s patented Protein-fragment Complementation Assay (PCA) technology measures pathway activity within living cells and is applied...

Southern Research Institute Announces Joint Drug D...

BIRMINGHAM, Ala., May 9 /PRNewswire/ — Southern Research Institute today announced that it has entered into a joint collaborative research program with Schering-Plough Corporation (NYSE: SGP – News) to discover novel compounds as potential new products to treat infectious disease. Building on leads generated from Southern Research’s proprietary compound repository, scientists from both companies will...
Page 34 of 34« First...1020...3031323334